311
Participants
Start Date
February 1, 2021
Primary Completion Date
October 20, 2021
Study Completion Date
December 20, 2021
Tinzaparin
"day subcutaneously • Follow-up phase 1 (Day 15 to day 30): The information is obtained at discharge and on day +14, + 28 on 30 days. The latter information is obtained from patients, from medical records or by telephone contact at the patient's home.~• Follow-up phase 2 (At 3 months: Information is obtained from patients, medical records, or by telephone contact at the patient's home."
Complejo Hospitalario Universitario A Coruña, A Coruña
Hospital Universitario del Vinalopó, Alicante
Hospital Clínic Barcelona, Barcelona
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Universitario de Burgos, Burgos
Hospital Virgen de la Luz, Cuenca
Hospital Universitari de Girona Doctor Josep Trueta, Girona
Hospital Clínico San Carlos, Madrid
Hospital de Emergencias Enfermera Isabel Zendal, Madrid
Hospital General Universitario Gregorio Marañón, Madrid
Hospital Universitario 12 Octubre, Madrid
Hospital Universitario Infanta Leonor, Madrid
Hospital Universitario Infanta Sofía, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Complexo Hospitalario Universitario de Pontevedra, Pontevedra
Hospital Clínico Universitario de Valencia, Valencia
Hospital Clínico Universitario de Valladolid, Valladolid
Hospital Álvaro Cunqueiro, Vigo
Hospital Universitario Infanta Leonor
OTHER